Lozol: Effective Blood Pressure Control with Indapamide
| Product dosage: 1.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.47 | $44.13 (0%) | 🛒 Add to cart |
| 60 | $1.02 | $88.25 $61.18 (31%) | 🛒 Add to cart |
| 90 | $0.88 | $132.38 $79.23 (40%) | 🛒 Add to cart |
| 120 | $0.80 | $176.51 $96.28 (45%) | 🛒 Add to cart |
| 180 | $0.73 | $264.76 $131.38 (50%) | 🛒 Add to cart |
| 270 | $0.68 | $397.14 $183.53 (54%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $529.52 $235.68 (55%) | 🛒 Add to cart |
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.14 | $64.18 (0%) | 🛒 Add to cart |
| 60 | $1.52 | $128.37 $91.26 (29%) | 🛒 Add to cart |
| 90 | $1.30 | $192.55 $117.34 (39%) | 🛒 Add to cart |
| 120 | $1.20 | $256.74 $143.41 (44%) | 🛒 Add to cart |
| 180 | $1.09 | $385.10 $196.56 (49%) | 🛒 Add to cart |
| 270 | $1.02 | $577.66 $275.79 (52%) | 🛒 Add to cart |
| 360 | $0.99
Best per pill | $770.21 $355.02 (54%) | 🛒 Add to cart |
Lozol (indapamide) is a thiazide-like diuretic medication prescribed for the management of hypertension and edema associated with congestive heart failure. As a first-line antihypertensive agent, it works by promoting the excretion of sodium and water from the body, thereby reducing blood volume and peripheral vascular resistance. Its well-established efficacy and favorable pharmacokinetic profile make it a cornerstone in cardiovascular risk management strategies, particularly for patients requiring gentle yet consistent diuresis without significant electrolyte disruption when used appropriately.
Features
- Contains indapamide 1.25 mg or 2.5 mg as the active pharmaceutical ingredient
- Thiazide-like sulfonamide diuretic with vasodilatory properties
- Once-daily oral administration for enhanced patient compliance
- Bioavailability of approximately 93% with peak plasma concentrations reached within 2-3 hours
- Extensive hepatic metabolism with renal elimination of metabolites
- Plasma half-life of 14-18 hours allowing for sustained 24-hour therapeutic effect
Benefits
- Effectively lowers systolic and diastolic blood pressure through dual diuretic and vasodilatory mechanisms
- Reduces risk of stroke, myocardial infarction, and other cardiovascular events associated with hypertension
- Minimizes fluid retention in heart failure patients, improving exercise tolerance and reducing edema
- Maintains potassium balance better than conventional thiazide diuretics when used at recommended doses
- Simplifies treatment regimen with single daily dosing convenience
- Cost-effective therapeutic option with proven long-term cardiovascular protection
Common use
Lozol is primarily indicated for the treatment of essential hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also prescribed for salt and fluid retention associated with congestive heart failure. Physicians may consider Lozol particularly suitable for elderly hypertensive patients and those with mild to moderate hypertension where gentle diuresis is desired. The medication demonstrates excellent efficacy in volume-dependent hypertension and shows particular benefit in salt-sensitive hypertensive populations.
Dosage and direction
The recommended initial dosage for hypertension is 1.25 mg once daily in the morning. Depending on therapeutic response, the dosage may be increased to 2.5 mg daily after 4 weeks of treatment. For edema in congestive heart failure, the initial dose is 2.5 mg once daily. Administration should occur with or without food, preferably in the morning to minimize nocturnal diuresis. Tablets should be swallowed whole with a glass of water. Regular monitoring of blood pressure, serum electrolytes, and renal function is recommended during therapy, especially during dosage adjustments.
Precautions
Patients should maintain adequate hydration while avoiding excessive fluid intake. Regular monitoring of serum potassium, sodium, creatinine, and uric acid levels is essential, particularly during initial treatment and after dosage changes. Caution is advised in patients with hepatic impairment due to potential for precipitated hepatic encephalopathy. Use with care in patients with diabetes mellitus as hyperglycemia may occur. Photosensitivity reactions have been reported—appropriate sun protection measures are recommended. Elderly patients may require lower initial doses due to age-related decline in renal function.
Contraindications
Lozol is contraindicated in patients with known hypersensitivity to indapamide, other sulfonamide-derived drugs, or any component of the formulation. It should not be used in patients with severe renal impairment (creatinine clearance below 30 mL/min), anuria, or hepatic encephalopathy. Contraindications include pre-existing significant hypokalemia, hyponatremia, or hypercalcemia. The medication is not recommended during breastfeeding due to secretion in human milk.
Possible side effect
Common adverse reactions include dizziness, headache, fatigue, and muscle cramps (incidence 3-8%). Gastrointestinal disturbances such as nausea, constipation, and dry mouth may occur in approximately 2-5% of patients. Orthostatic hypotension affects about 1-3% of users, particularly during initial therapy. Less frequent side effects include rash, photosensitivity, impotence, and palpitations. Laboratory abnormalities may include hypokalemia (5-10%), hyperuricemia (3-6%), hyponatremia (1-3%), and slight increases in blood glucose and creatinine levels.
Drug interaction
Concurrent use with other antihypertensive agents may potentiate blood pressure lowering effects. NSAIDs may reduce the antihypertensive efficacy of indapamide. Corticosteroids and amphotericin B may increase the risk of hypokalemia. Lithium levels may increase due to reduced renal clearance, potentially leading to lithium toxicity. Indapamide may enhance the effects of neuromuscular blocking agents. Caution is advised with digoxin due to increased risk of arrhythmias in hypokalemic states. The diuretic effect may be diminished when used with cholestyramine or colestipol.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If remembered near the time of the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Patients should never double the dose to make up for a missed administration. Consistent daily dosing is important for maintaining stable blood pressure control, but occasional missed doses are unlikely to significantly affect long-term hypertension management.
Overdose
Symptoms of overdose include profound electrolyte disturbances (particularly hypokalemia and hyponatremia), dehydration from excessive fluid loss, hypotension, dizziness, gastrointestinal disturbances, and impaired consciousness. Severe cases may progress to cardiac arrhythmias or shock. Management involves gastric lavage if ingestion was recent, followed by activated charcoal administration. Treatment is primarily supportive with careful correction of fluid and electrolyte imbalances, particularly potassium replacement. Hemodialysis is not effective due to high protein binding. Cardiovascular monitoring is essential until stabilization is achieved.
Storage
Store at controlled room temperature between 20-25°C (68-77°F). Protect from light and moisture. Keep in the original container with the lid tightly closed. Do not transfer tablets to other containers. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly discard any medication that appears discolored, shows signs of deterioration, or is no longer needed.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual patient needs may vary, and healthcare professionals should exercise clinical judgment when prescribing Lozol. The prescribing physician should be consulted for specific medical advice, diagnosis, and treatment recommendations. Full prescribing information including boxed warnings should be reviewed before initiation of therapy. Patients should not discontinue or adjust medication without consulting their healthcare provider.
Reviews
Clinical studies demonstrate that Lozol maintains blood pressure control in 60-70% of mild to moderate hypertensive patients as monotherapy. Combination therapy success rates exceed 85% when used with other antihypertensive agents. Long-term outcome studies show consistent reduction in cardiovascular events with sustained use. Patient satisfaction surveys indicate high compliance rates due to once-daily dosing and generally favorable side effect profile compared to older diuretics. Healthcare providers report particular satisfaction with its metabolic profile and reliability in diverse patient populations.